Adverse left ventricular remodelling after acute myocardial infarction: is there a simple treatment that really works?

Early short-term doxycycline therapy in patients with acute myocardial infarction and left ventricular dysfunction to prevent the ominous progression to adverse remodelling: the TIPTOP trial

(2013) G. Cerisano et al.   EUROPEAN HEART JOURNAL

Adult Bone Marrow Cell Therapy Improves Survival and Induces Long-Term Improvement in Cardiac Parameters

(2012) Vinodh Jeevanantham et al.   CIRCULATION

Matrix metalloproteinase inhibition therapy for vascular diseases

(2012) Andrew C. Newby   VASCULAR PHARMACOLOGY

New Targets to Treat the Structural Remodeling of the Myocardium

(2011) Arantxa González et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Temporal and Spatial Expression of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases Following Myocardial Infarction

(2010) Merry L. Lindsey et al.   Cardiovascular Therapeutics

Matrix Metalloproteinase Inhibition Improves Cardiac Dysfunction and Remodeling in 2-Kidney, 1-Clip Hypertension

(2010) Élen Rizzi et al.   JOURNAL OF CARDIAC FAILURE

Clinical studies on the management of periodontal diseases utilizing subantimicrobial dose doxycycline (SDD)

(2010) Jack Caton et al.   PHARMACOLOGICAL RESEARCH

Pharmacological Intervention for Prevention of Left Ventricular Remodeling and Improving Prognosis in Myocardial Infarction

(2008) Hideki Ishii et al.   CIRCULATION